Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Transaction in Own Shares

27 Feb 2024 17:43

Worldwide Healthcare Trust Plc - Transaction in Own Shares

Worldwide Healthcare Trust Plc - Transaction in Own Shares

PR Newswire

LONDON, United Kingdom, February 27

For immediate release

27 February 2024

WORLDWIDE HEALTHCARE TRUST PLC(the "Company")

MARKET PURCHASE OF COMPANY’S OWN SHARES

This notification is given, pursuant to the authority granted at an Annual General Meeting of the Company held on 18 July 2023 to make market purchases of the Company’s own shares up to an aggregate maximum of 90,189,613.

The Company has purchased a market total of 571,530 Ordinary shares of 2.5p each in the capital of the Company today at a price of 331.55 pence per share. These shares will be held in treasury.

Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 48,461,006 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 553,204,194.

The figure of 553,204,194 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure and Transparency Rules.

For and on behalf of

Frostrow Capital LLP

Company Secretary

For further information, please contact:

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913



Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.